Dupixent (dupilumab) is a brand-name injectable ... Dupixent comes in two forms: pens and syringes. Each pen or syringe is prefilled with a single dose of Dupixent. Your doctor or another ...

EYLEA HD achieved $6 billion in 2024 sales, with FDA decisions on extended dosing and pre-filled syringes due in 2025 ... Dupixent (dupilumab) is now used to treat over a million patients globally.

Dupixent (dupilumab) is a brand-name injection ... Dupixent is available as a solution inside single-dose prefilled pens and syringes, given as a subcutaneous injection. Dupixent is a biologic ...

results EYLEA HD pre-filled syringe (PFS) submission completed; launch expected by mid-2025 Libtayo ® exceeded $1 billion in 2024 annual net sales, and becomes the first and only immunotherapy to ...

At the moment the biologic is delivered as a pre-filled syringe (pictured above ... such as Sanofi/Regeneron's IL-4/IL-13 inhibitor Dupixent (dupilumab) and AZ's IL-5 inhibitor Fasenra ...

Inclusion criteria: (1) Children and adolescents aged 6 months to younger than 18 years; (2) Pediatric patients treated with dupilumab injection (300 mg/2.0 ml/vial or 200 mg/1.14 ml/vial pre-filled ...

The FDA will review a new prefilled syringe presentation of Shingrix (zoster vaccine recombinant, adjuvanted).

EYLEA HD is anticipated to gain traction with the launch of a prefilled syringe in mid-2025 and label expansions for macular edema and extended dosing intervals. Management believes these developments ...

GSK plc (LSE/NYSE: GSK) today announced that the European Medicines Agency (EMA) has accepted for review the regulatory application of a prefilled syringe presentation of Shingrix (GSK’s Recombinant ...

The new prefilled syringe removes the need to reconstitute separate vials prior to administration, offering a convenient option for physicians, pharmacists and other healthcare professionals who ...

GSK plc announced that the European Medicines Agency (EMA) has accepted for review the regulatory application of a prefilled syringe presentation of Shingrix (GSK’s Recombinant Zoster Vaccine or RZV) ...

The differences between PFSs and MDVs (per 1000 doses) is 324.21. MDV: Multidose vial; NA: Not available; PFS: Prefilled syringe. Prefilled syringes (PFSs) have gained market share in the USA ...